Lyman GH - Search Results

1

A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Lyman GH, Green SJ, Ravdin PM, Geyer CE Jr, Russell CA, Balcerzak SP, Thomas Budd G, Martino S; Southwest Oncology Group Randomized Phase II Study. Lyman GH, et al. Breast Cancer Res Treat. 2004 May;85(2):143-50. doi: 10.1023/B:BREA.0000025405.63953.f9. Breast Cancer Res Treat. 2004. PMID: 15111772 Clinical Trial.

2

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

Kumar NB, Allen K, Cantor A, Cox CE, Greenberg H, Shah S, Lyman GH. Kumar NB, et al. Among authors: lyman gh. Breast Cancer Res Treat. 1997 Jun;44(2):135-43. doi: 10.1023/a:1005721720840. Breast Cancer Res Treat. 1997. PMID: 9232272

3

Quality of life after adjuvant chemotherapy for breast cancer.

Broeckel JA, Jacobsen PB, Balducci L, Horton J, Lyman GH. Broeckel JA, et al. Among authors: lyman gh. Breast Cancer Res Treat. 2000 Jul;62(2):141-50. doi: 10.1023/a:1006401914682. Breast Cancer Res Treat. 2000. PMID: 11016752

4

Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.

Lyman GH, Delgado DJ. Lyman GH, et al. Cancer. 2003 Dec 1;98(11):2402-9. doi: 10.1002/cncr.11827. Cancer. 2003. PMID: 14635075 Free article.

5

Evidence-based use of colony-stimulating factors in elderly cancer patients.

Lyman GH, Kuderer N, Agboola O, Balducci L. Lyman GH, et al. Cancer Control. 2003 Nov-Dec;10(6):487-99. doi: 10.1177/107327480301000607. Cancer Control. 2003. PMID: 14652525 Free article. Review.

6

Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.

Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M; OPPS Working Group; ANC Study Group. Lyman GH, et al. Leuk Lymphoma. 2003 Dec;44(12):2069-76. doi: 10.1080/1042819031000119262. Leuk Lymphoma. 2003. PMID: 14959849

7

Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.

Lyman GH, Dale DC, Friedberg J, Crawford J, Fisher RI. Lyman GH, et al. J Clin Oncol. 2004 Nov 1;22(21):4302-11. doi: 10.1200/JCO.2004.03.213. Epub 2004 Sep 20. J Clin Oncol. 2004. PMID: 15381684

8

The economic burden of anemia in cancer patients receiving chemotherapy.

Lyman GH, Berndt ER, Kallich JD, Erder MH, Crown WH, Long SR, Lee H, Song X, Finkelstein SN. Lyman GH, et al. Value Health. 2005 Mar-Apr;8(2):149-56. doi: 10.1111/j.1524-4733.2005.03089.x. Value Health. 2005. PMID: 15804323 Free article.

9

Undertreatment of obese women receiving breast cancer chemotherapy.

Griggs JJ, Sorbero ME, Lyman GH. Griggs JJ, et al. Among authors: lyman gh. Arch Intern Med. 2005 Jun 13;165(11):1267-73. doi: 10.1001/archinte.165.11.1267. Arch Intern Med. 2005. PMID: 15956006

10

The challenge of systematic reviews of diagnostic and staging studies in cancer.

Lyman GH, Djulbegovic B. Lyman GH, et al. Cancer Treat Rev. 2005 Dec;31(8):628-39. doi: 10.1016/j.ctrv.2005.07.001. Epub 2005 Oct 12. Cancer Treat Rev. 2005. PMID: 16225994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters